09:15 – 10:05
Room: TELUS Exhibit Hall E
The lecturer will describe what he has learned about diagnosis in emergency care in the past 25 years as an emergency physician and researcher. The talk describes a personal and philosophical shift from creating research success, toward creating humanism in how emergency physicians generate diagnostic hypotheses. In particular, the talk describes how weak empathy can be a root cause of diagnostic error (which includes failures as well as over testing) and a focus on what we can do at the bedside to improve empathy to reduce cognitive error.
Delegates who attend Dr. Kline’s session will be able to:
- Define intuitive diagnostic hypothesis generation including its magnitude of effect on decision making and time required.
- Describe one way to enhance patient perception that you are an empathic doctor
- Describe the relationship between empathy failure and faulty diagnostic hypothesis generation
Dr. Jeffrey Kline received his MD from the Medical College of Virginia, and then did an emergency medicine residency followed by a research fellowship the Carolinas Medical Center. He now serves as Vice Chair of Research in emergency medicine and a professor of physiology at Indiana University School of Medicine. He is the present Editor In Chief of Academic Emergency Medicine. His research interest focuses on blood clots, the people who have them, and the people who diagnose and treat them.
In the area of diagnosis, Kline’s main interests are in intuitive decision making, pretest probability and capnography to reduce medical imaging. His human treatment research includes mechanisms of resistance to fibrinolysis, use of the cyclic guanosine monophosphate signaling pathway to overcome pulmonary vasospasm and platelet hyperactivation during PE. His laboratory work focuses on mechanisms and treatment of acute pulmonary hypertension and platelet hyperactivation from pulmonary embolism. He is the cofounder of Indian Lysis Technologies LLC, a company that seeks to translate nanoparticle-delivered plasmin for clot lysis into clinical use.